ARTICLE | Clinical News
Lenti-D gene therapy: Additional Phase I data
June 7, 2010 7:00 AM UTC
Additional data from a French Phase I trial in 3 patients with ALD showed that Lenti-D gene therapy led to continued stable expression of ALD protein, with expression in 10-15% of monocytes, and disea...